ORASURE TECHNOLOGIES INC
About ORASURE TECHNOLOGIES INC
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $115.0M
- Net income
- -$68.7M
- Total assets
- $403.2M
- Market cap
- $278.1M
- Gross margin
- 41.9%
- Operating margin
- -62.6%
- Net margin
- -59.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $115.0M
- Cost of revenue
- $66.8M
- Gross profit
- $48.2M
- Operating expenses
- $120.2M
- Operating income
- -$72.0M
- Income tax
- $1.8M
- Net income
- -$68.7M
- EPS (basic)
- $-0.94
- EPS (diluted)
- $-0.94
Balance sheet
- Total assets
- $403.2M
- Current assets
- $261.9M
- Total liabilities
- $62.3M
- Current liabilities
- $39.8M
- Shareholders’ equity
- $340.8M
Cash flow
- Operating cash flow
- -$49.0M
- Investing cash flow
- -$6.8M
- Financing cash flow
- -$16.9M
- Net cash flow
- -$72.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $278.1M
- EPS (diluted)
- $-0.94
- Shares outstanding
- 67.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 17, 1986
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $68.7M in FY2025.
- Revenue declined 51% from FY2021 to FY2025.
- Gross margin of 41.9%, net margin -59.8%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ORASURE TECHNOLOGIES INC.
Write a review
News about ORASURE TECHNOLOGIES INC
News & sentiment via Polygon.io
